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Interactions between inducible nitric oxide synthase and heme
oxygenase-1 in glomerulonephritis
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Interactions between inducible nitric oxide synthase and heme activated in inflammation. Such enzymes include iNOS,
oxygenase-1 in glomerulonephritis. cyclooxygenase and cytochrome P450 monooxygenases.
Background. In anti-glomerular basement membrane (GBM) Degradation of heme by HO-1 can, therefore, limit hemenephritis, inducible nitric oxide synthase (iNOS) and heme oxy-
availability for synthesis or optimal activity of these en-genase (HO-1) are co-induced. Moreover, in glomerular mes-
zymes. This may reduce synthesis of proinflammatory me-angial cells iNOS-derived nitric oxide (NO) production stimu-
lates HO-1 while HO-1 activation reduces iNOS expression/ diators such as prostaglandins and thromboxane from
activity. These observations prompted us to explore regulatory activation of cyclooxygenase and arachidonate epoxides
interactions between iNOS and HO-1 in anti-GBM nephritis. from activation of cytochrome P450 monooxygenases, and
Methods. Rats with anti-GBM nephritis were pretreated with
attenuate formation of prooxidant byproducts, that is,the iNOS inhibitor l-N6-(1-iminoethyl) lysine (L-NIL) or with
NO derived from iNOS activation and reactive oxygenthe HO-1 inducer hemin. Glomerular HO-1 levels were assessed
by Western blot analysis. iNOS activity was assessed by calcu- metabolites derived from activation of cytochrome P450
lating conversion of l-arginine to l-citrulline. monoxygenases during NADPH-dependent electron trans-
Results. iNOS inhibition reduced glomerular HO-1 levels fer. An overall anti-inflammatory/antioxidant effect can
without altering the inflammatory response to anti-GBM anti-
thus be expected as a result of HO-1 activation. Support-body induced injury. Induction of HO-1 reduced glomerular
ing this hypothesis, it was shown that HO-1 inductioniNOS activity.
Conclusions. In anti-GBM nephritis iNOS up-regulates HO-1 protects from chemically induced inflammation in the
presumably via high output NO production. Suprainduction of pleural cavity [5], and protects renal tubules from myo-
HO-1 attenuates iNOS activity. This negative feedback interac- globin or hemoglobin induced injury [6]. It was further
tion points to HO-1 as a target for pharmacologic manipulation
shown that HO-1 induction prolongs survival of cardiacto reduce activity of prooxidant heme containing enzymes such
xenografts in mice and protects against chronic rejectionas iNOS.
[7, 8]. Finally, two independent studies demonstrated that
HO-1 induction attenuates proteinuria in the rat model
of anti-GBM nephritis [2, 9]. The mechanism of enhancedIn experimental glomerulonephritis, as exemplified in
HO-1 expression in glomerulonephritis is unknown. Inthe model of anti-glomerular basement membrane (anti-
previous studies we reported that NO derived from NOGBM) antibody induced nephritis, there is enhanced ex-
donors or from iNOS activation by cytokines stimulatespression and enzyme activity of the inducible nitric oxide
HO-1 expression and activity in glomerular mesangialsynthase (iNOS) and of heme oxygenase-1 (HO-1) in glo-
cells [10]. This, and the observation that iNOS and HO-1meruli [1, 2]. iNOS activation results in a sustained high
are coactivated within nephritic glomeruli, prompted usoutput production of nitric oxide (NO), which can cause
to explore regulatory interactions between these two en-oxidative injury either on its own or by interacting with
zyme systems. We employed the rat model of anti-GBMthe superoxide anion to form the relatively stable pro-
nephritis to explore whether iNOS activation stimulatesoxidant peroxynitrite (ONOO) [3]. HO-1 is the induc-
HO-1 expression and whether HO-1 induction attenu-ible isoform of heme oxygenase. It catalyzes the NADPH,
ates iNOS activity.O2 and cytochrome P450 reductase-dependent oxidation
of heme to carbon monoxide, iron and biliverdin, which
is reduced to bilirubin by biliverdin reductase [4]. Heme METHODS
is a key constituent of a number of enzymes that are
Development of anti-GBM nephritis
Male Lewis rats weighing 175 to 200 g were immunized
Key words: iNOS, HO-1, nephritis, oxidative injury, inflammation. intraperitoneally with 1 mg of rabbit IgG emulsified in
complete Freund’s adjuvant and given as a total volume 2002 by the International Society of Nephrology
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Fig. 1. Western blot analyses of the rat mac-
rophage marker, ED1, and heme oxygenase-1
(HO-1) in protein lysates of glomeruli isolated
from rats treated with anti-glomerular base-
ment membrane (GBM) or non-immune se-
rum (NIS).
ately before use by dissolving in 0.1N NaOH adjusted
to pH 7.4 with 0.1N HCl, and further diluted in saline
for subcutaneous injections.
Western blot analyses of HO-1 and ED1 protein levels
in glomeruli
These analyses assessed glomerular levels of HO-1
and of the rat macrophage marker ED1 as an index of
the extent of infiltration of nephritic glomeruli by macro-
phages. Preparation of glomerular protein lysates andFig. 2. Glomeruli of nephritic rats not treated (lane 1) or treated with
hemin (lane 2). electrophoretic transfer of proteins were performed as
previously described [9, 10]. Membranes were incubated
either with rabbit polyclonal antibody against rat HO-1
(1:1000 dilution) obtained from StressGen Biotechnolo-of 0.5 mL. Seven days after this immunization, animals
gies (Vancouver, British Columbia, Canada), or with anti-were injected in the tail vein with two subnephritogenic
ED1 antibody (Serotec, Westbury, NY, USA), washeddoses (0.3 mL/100 g body wt given 24 hours apart) of rab-
thoroughly and incubated with anti-rabbit horseradishbit immune serum raised against rat particulate GBM.
peroxidase-conjugated second antibody. Detection ofThis protocol results in heavy proteinuria and acceler-
signal used an enhanced chemiluminescence detectionated onset of glomerular infiltration by macrophages,
kit (Amersham, Arlington Heights, IL, USA).crescent formation, and scarring [9]. Animals were ne-
phrectomized 24 hours after the second injection of anti- iNOS enzyme activity
rat GBM serum or of nonimmune rabbit serum (con-
Activity of iNOS in glomerular lysates was determinedtrols) and glomeruli were isolated by differential sieving
by calculating conversion of l-[14C]arginine to l-[14C]-of minced cortex.
citrulline as previously described [9]. Results were ex-
pressed as pmol citrulline/min.iNOS inhibition
The selective iNOS inhibitor l-N6-(1-iminoethyl) ly-
Urine nitrite excretionsine (L-NIL) was used (Dr. Mark G. Currie; The Mon-
Urinary excretion of nitrite was measured using thesanto Co., St. Louis, MO, USA) [11]. This inhibitor has
Griess reaction method and a commercially by availablean IC50 of 3.3 mol/L for macrophage iNOS compared
kit (Promega, Madison, WI, USA). Results were ex-to an IC50 of 92 mol/L for rat brain constitutive NOS
pressed as urine nitrite-to-urine creatinine ratio.indicating that L-Nil is 28-fold more selective for induc-
ible NOS. To prevent iNOS activation, 15 mg/kg of L-NIL
Statistical analyseswas injected in the tail vein 30 minutes prior to each
Data are expressed as mean  SEM. Comparisonsinjection of the anti-rat GBM immune serum.
used t test statistics for unpaired observations. P  0.05
Induction of HO-1 was considered significant.
We employed the HO-1 inducer hemin (Ferriproto-
porphyrin IX chloride; Sigma). Animals were injected RESULTS
subcutaneously with hemin, 30 mol/kg body wt, or with
iNOS inhibition reduces glomerular HO-1 levelssaline vehicle 24 hours before the first and second injec-
Pre-treatment of animals with anti-GBM nephritistion of anti-GBM serum or of rabbit nonimmune serum.
A solution of hemin (10 mmol/L) was prepared immedi- with L-NIL reduced urine nitrite excretion to 88.25 
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Fig. 3. Inducible nitric oxide synthase (iNOS)
activity in glomeruli of nephritic rats treated
with NIS, anti-GBM serum or hemin  anti-
GBM serum.
9.39 mol per mg creatinine compared to a value of regulates glomerular HO-1 in anti-GBM nephritis. Thus,
pretreatment with the selective iNOS inhibitor, L-NIL,839.51  315.70 in nephritic animals not pretreated with
in doses sufficient to reduce urine nitrite excretion, atten-L-NIL (P  0.05).
uated glomerular HO-1 protein levels. There was no ef-Figure 1 shows a Western blot analysis of ED1 and
fect on extent of glomerular infiltration by macrophagesHO-1 proteins in protein lysates prepared from glomer-
assessed as glomerular levels of the ED1 marker (Fig.uli isolated from animals that received anti-GBM serum
1). This indicates that the reduction in HO-1 levels ob-or from controls that received non-immune serum. In this
served in L-NIL treated animals was due to iNOS inhibi-experiment, two animals received non-immune serum
tion rather than to an alteration of the inflammatory(NIS) (lanes 1 and 2 in the upper and lower panels),
response to anti-GBM antibody-induced injury thatthree animals received anti-GBM serum (lanes 3, 4, 5 in
could have occurred as a result of the L-NIL treatment.the upper and lower panels) and three animals received
In its capacity as the rate-limiting enzyme of hemeanti-GBM serum and L-NIL treatment (lanes 6, 7, 8 in
degradation, HO-1 reduces cellular heme levels therebythe upper and lower panels). As expected, ED1 levels
limiting availability of heme for synthesis or enzymewere higher in nephritic glomeruli (upper panel; lanes
activity of heme containing enzymes such as iNOS. The3, 4, 5, 6, 7, 8) compared to controls (upper panel; lanes
present studies explored whether this occurs in the model
1 and 2). L-NIL treatment reduced HO-1 levels in ne- of anti-GBM nephritis. Pre-treatment with the HO-1
phritic glomeruli that received L-NIL (lanes 6, 7, 8 in inducer, hemin, augmented glomerular HO-1 levels (Fig.
lower panel) compared to levels in nephritic glomeruli 2) and significantly reduced glomerular iNOS enzyme
that did not receive L-NIL (lanes 3, 4, 5 in lower panel). activity (Fig. 3). This supports the presence of a negative
regulatory interaction between HO-1 and iNOS wherebySuprainduction of HO-1 reduces glomerular
induction of HO-1 reduces iNOS activity.iNOS activity
In summary, our studies demonstrate a negative feed-
Hemin treatment prior to administration of anti-GBM back interaction between iNOS and HO-1 in nephritic
serum increased HO-1 protein level in glomeruli of ne- glomeruli whereby iNOS activation up-regulates HO-1,
phritic animals (Fig. 2, lane 2) compared to the level in presumably via a sustained high output NO production,
glomeruli of nephritic animals that were not treated with and HO-1 induction attenuates iNOS activity. These ob-
hemin (Fig. 2, lane 1). In nephritic animals, iNOS enzyme servations point to HO-1 as a potential target for pharma-
activity in glomeruli was markedly increased (Fig. 3). cologic manipulation in order to enhance its expression/
activity in glomerulonephritis. This may have a beneficialHemin pre-treatment significantly reduced glomerular
effect by reducing activity of proinflammatory/prooxidantiNOS activity (Fig. 3).
heme-containing enzymes such as iNOS, cyclooxygenase
and the cytochrome P450 monooxygenases.
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